Erythropoietic protoporphyria

Photodermatology Photoimmunology and Photomedicine

Volumn 19, Issue 3, 2003, Pages 142-146

  Lecha, M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BETA CAROTENE; CHENODEOXYCHOLIC ACID; COLESTYRAMINE; CYSTEINE; FERROCHELATASE; URSODEOXYCHOLIC ACID;

ANEMIA; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL FEATURE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFECT; ERYTHEMA; ERYTHROPOIETIC PROTOPORPHYRIA; GENE MUTATION; HISTOLOGY; HUMAN; LIVER DISEASE; PATHOGENESIS; PETECHIA; PHOTOSENSITIVITY; PHOTOTHERAPY; PRIORITY JOURNAL; SKIN EDEMA; ULTRAVIOLET B RADIATION;

HUMANS; PORPHYRIA, ERYTHROPOIETIC;

EID: 0038718072     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0781.2002.00009.x     Document Type: Article

References (32)

1. Kosenow W, Treibs A. Lichtüberempfindlichkeit und Porphyrinämie. Z Kinderheilkd 1953; 73: 82-92.
2. Magus IA, Jarrett A, Prankerd TAJ, Rimington C. Erythropoietic protoporphyria: a new porphyria syndrome with solar urticaria due to protoporphyrinaemia. Lancet 1961; 2: 448-451.
3. Todd DJ. Erythropoietic protoporphyria. Br J Dermatol 1994; 131: 450-454.
4. Cox TM, Graeme JM, Alexander MD, Sarkany RP. Protoporphyria. Seminars in Liver Disease 1998; 18: 85-93.
5. Schmidt H, Snitker G, Thomsen K, Lintrup J. Erythropoietic protoporphyria: a clinical study based on 29 cases in 14 families. Arch Dermatol 1974; 110: 58-64.
6. Henderson CA, Elder GH. Erythropoietic protoporphyria presenting in an adult. J R Soc Med 1995; 8: 476-477.
7. Aplin C, Whatley SD, Thompson P et al. Late-onset erythropoietic porphyria caused by a chromosome 18q deletion in erythroid cells. J Invest Dermatol 2001; 117: 1647-1649.
8. Poh-Fitzpatrick MB. The priming phenomenon in the acute phototoxicity of erythropoietic protoporphyria. J Am Acad Dermatol 1989; 21: 311-312.
9. Thunell S, Harper P, Brun A. Porphyrins, porphyrin metabolism and porphyries. IV. Pathophysiology of erythropoietic protoporphyria - diagnosis, care and monitoring of the patient. Scand J Clin Lab Invest 2000; 60: 581-604.
10. Schmidt GF, Wolff K, Konrad K. Erythropoietic protoporphyria - submicroscopic events during the acute photosensitivity flare. Br J Dermatol 1975; 92: 545-557.
11. Poh-Fitzpatrick MB. Porphyrin-sensitized cutaneous photosensitivity: pathogenesis and treatment. Clin Dermatol 1985; 3: 41-82.
12. Glover RA, Bailey CS, Barrett K, Wasserman DI, Gigli I. Histamine release from rodent and human mast cells induced by protoporphyrin and ultraviolet light: studies of the mechanism of mast-cell activation in erythropoietic protoporphyria. Br J Dermatol 1990; 122: 501-512.
13. Lim HW, Poh-Fitzpatrick MB, Gigh I. Activation of the complement system in patients with porphyrias after irradiation in vivo. J Clin Invest 1984; 74: 1961-1965.
14. Mathews-Roth MM. Anemia in erythropoietic protoporphyria. JAMA 1974; 230: 824.
15. Bloomer JR. The liver in protoporphyria. Hepatology 1988; 8: 402-407.
16. Matilla A, Molland EA. A light and electron microscopic study of the liver in case of erythropoietic protoporphyria and in griseofulvin-induced porphyria in mice. J Clin Path 1974; 27: 698-709.
17. Muley SA, Midani HA, Rank JM, Carithers R, Parry GJ. Neuropathy in erythropoietic protoporphyrias. Neurology 1998; 51: 262-265.
18. Lim HW. Pathophysiology of cutaneous lesions in porphyrias. Semin Hemato 1989; 26: 114-119.
19. Todd DJ. Erythropoietic protoporphyria. Br J Dermatol 1994; 131: 751-766.
20. Scholwick P, Marver H, Schmid R. Erythropoietic protoporphyria: evidence for multiple sites of excess protoporphyrin formation. J Clin Invest 1971; 50: 203-207.
21. Nunn AVW, Norris P, Hawk JLM, Cox TM. Zinc chelatase in human lymphocytes: detection of the enzymatic defect in erythropoietic protoporphyria. Anal Biochem 1988; 174: 146-150.
22. Sarkany RP, Alexander GJ, Cox TM. Recessive inheritance of erythropoietic protoporphyria with liver failure. Lancet 1994; 344: 958-959.
23. Gouya L, Deybach JC, Lamoril J et al. Modulation of the phenotype in dominant erythropoietic protoporphyria by a low level expression of the normal ferrochelatase allele. Am J Hum Genet 1996; 58: 292-299.
24. Whitcombe DM, Albeertson DDG, Smith SJ, Rhodes DA, Cox TM. Assignment of the human ferrochelatase gene (FECH) and a locus for protoporphyria to chromosome 18q22. Genomics 1991; 11: 1152-1154.
25. Corbett MF, Herxheimer A, Magnus IA et al. The longterm treatment with betacarotene in erythropoietic protoprophyria: a controlled trial. Br J Dermatol 1977; 97: 655-662.
26. Mathews-Roth MM, Rosner B, Benfell K et al. A double-blind study of cysteine photoprotection in erythropoietic protoporphyria. Photodermatol Photimmunol Photomed 1994; 10: 244-248.
27. Todd DJ. Therapeutic options for erythropoietic protoprohyria. Br J Dermatol 2000; 142: 826.
28. Mathews-Roth MM. Treatment of the cutaneous porphyrias. Clin Dermatol 1998; 16: 295-298.
29. Meerman L, Haagsma EB, Gouw AS, Slooff JH, Jansen PL. Long term follow-up after liver transplantation for erythropoietic protoporphyria. Eur J Gastroenterol Hepatol 1999; 11: 431-438.
30. Gordeux VR, Brittenham GM, Hawkins CW, Mukhtar H, Bickers DR. Iron therapy for hepatic dysfunction in erythropoietic protoporphyria. Ann Intern Med 1986; 105: 27-31.
31. Pirlich M, Lochs H, Hartmut H, Schmidt J. Liver cirrhosis in erythropoietic protoporphyria: improvement of liver function with ursodeoxycholic acid. Am J Gastroenterol 2001; 96: 3468-3469.
32. Meerman L, Verwer R, Slooff MJ et al. Perioperative measures during Liver Transplantation for Erythropoietic Protoprphyria. Transplantation 1994; 57: 155-158.